The markets opened higher with the Dow climbing 73 points to 18,193 as the Federal Open Market Committee met today. Nasdaq gained 15 points to 5,250.
On the upside
Tobira Therapeutics (Nasdaq: TBRA) will be acquired by Allergan (NYSE: AGN) in a deal valued at approximately $1.7 billion.
Great Basin Scientific (Nasdaq: GBSN) launched its Staph ID/R Blood Culture Panel in the U.S. and Europe.
Shares of Sarepta Therapeutics (Nasdaq: SRPT) continued climbing.
On the downside
Ascena Retail Group (Nasdaq: ASNA) reported fourth quarter earnings that fell short of expectations and forecast full year results below estimates.
Investors locked in profits on Community Health Systems (NYSE: CYH).
Encana (NYSE: ECA) priced its public offering of 107 million common shares at the discounted price of $9.35 per share.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 gained 8 points to 2,147. Bitcoin held steady at $609.
